Subscribe to PRO at just Rs.33 per month. Use code SUPERPRO
you are here: HomeNewsIndia
Last Updated : Apr 04, 2020 02:09 PM IST | Source: PTI

Coronavirus pandemic | CK Birla Group commits Rs 35 cr in support of the fight against COVID-19

Besides, the employees of each of the group companies are making voluntary personal contributions towards this fund, which will be added to this corpus.

Representative image
Representative image
  • bselive
  • nselive
Todays L/H

CK Birla group on April 4 said it will contribute Rs 35 crore to help the government fight against COVID-19 pandemic. As part of that, the conglomerate will contribute Rs 25 crore in the PM-CARES fund and rest would be to support the state governments and to supply medical equipment, it said in a statement.

"The CK Birla Group, Amita and CK Birla, have made a commitment of Rs 35 crores to support the Government in the fight against COVID-19. Rs 25 crores will be contributed to the PM-CARES Fund, and the remaining amount is being directed towards State Government funds and supplying equipment, masks, PPE's," it said.

Hospitals owned by the CK Birla group at Kolkata and Jaipur are working with the respective state governments.


Besides, the employees of each of the group companies are making voluntary personal contributions towards this fund, which will be added to this corpus.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

"The COVID-19 crisis is the defining crisis of our times, and our response, support and efforts will go a long way towards shaping our nation's ability to successfully overcome this," the group said.

CK Birla group has interests in sectors such as technology and automotive, building, healthcare and education.

It owns AVTEC, BirlasoftHILOrient CementOrient Electric and Orient Paper.

India is presently going through an unprecedented lockdown of three weeks, ending on April 14, to prevent the spread of the virus.

According to the latest report from the Union Health Ministry, the total number of COVID-19 cases climbed over 2,902 and the death count at 68.
First Published on Apr 4, 2020 01:55 pm